Zura Bio Ltd (ZURA) Wheel Strategy

Running a ZURA wheel strategy lets you generate consistent premium income on Zura Bio Ltd while setting your own entry and exit prices on the underlying. Zura Bio Ltd's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own ZURA, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best ZURA wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on ZURA, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable ZURA wheel from a losing one.

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the ZURA wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your ZURA wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.